ulrich medical USA® Announces FDA Clearance for Expanded Indications of Momentum® and Momentum® MIS Systems

Expanded indications allow Posterior Spinal Fixation Systems to be used with V-STEADY Bone Cement for bone tumor management 

PLANO, TexasDec. 20, 2023 /PRNewswire/ — ulrich medical USA, the pioneer in expandable corpectomy devices and a market leader in spine technology, today announced FDA clearance for expanded indications of the Momentum and Momentum MIS Posterior Spinal Fixation Systems. The expanded indications allow for both Momentum and Momentum MIS systems to be used in conjunction with G21 V-STEADY Radiopaque Bone Cement to help restore the integrity of the spinal column in patients with advanced stage tumors.

Momentum and Momentum MIS Posterior Spinal Fixation Systems and V-STEADY Bone Cement

“I’m excited that I can now use Momentum in conjunction with V-STEADY,” said Alekos Theologis, MD, Assistant Professor of Orthopedic Spine Surgery at UCSF Health. “Momentum has been a valuable treatment option and this enhancement will be beneficial to a segment of my patients.”

The Momentum and Momentum MIS Posterior Spinal Fixation Systems are used to provide stabilization, fixation and correction of the thoracolumbar and sacroiliac spine. These fixation systems enable surgeons to manage a comprehensive range of adult degenerative and deformity cases, including connections from occiput to pelvis, bone cement augmentation, and revisions for adjacent segment disease in restoration of spinal alignment in open or percutaneous procedures.

“We are pleased to have received this expanded indication from the FDA”, said Eric Lucas, Ph.D., Vice President of Technology at ulrich medical USA. “The combination of Momentum with V-STEADY offers our surgeon customers a new treatment option to support their most challenging patients.”

About ulrich medical USA

ulrich medical USA, headquartered in Plano, Texas is a subsidiary of ulrich medical, an innovative medical technology company headquartered in Ulm, Germany. Founded in 1912 by Heinrich C. Ulrich, the family-owned, privately held company is focused on the development, manufacturing and marketing of cutting-edge medical technology that restores function and alignment of the spine through excellence in design and manufacturing. Pioneers of expandable technology, surgeons worldwide have trusted in ulrich products for over 100 years.

US designed technology, German manufacturing integrity.

Information on ulrich medical USA and its complete line of surgical solutions for spine pathologies can be found at

SOURCE Ulrich Medical USA

#NASS #ulrichmedicalusa #spine

ulrich medical USA® Announces First MIS Case — using Momentum® Minimally Invasive Surgery System.

We are proud to announce our 1st MIS Case — using Momentum® Minimally Invasive Surgery System. We thank Grant Buttram, MD, MBA, FAANS, FACS who said, “Momentum MIS performs precisely as a minimally invasive system should. It is low profile, yet solidly designed, intuitive with a focus on patient safety, and will be facile to even those new to MIS surgery. Allowing surgeons to achieve strong fixation through the most minimal of incisions, it is a true pleasure to use,”

“ulrich is well known as a pioneer and global leader in the Vertebral Body Replacement space. In recent years we have been gaining success and popularity with our full spine portfolio. Now, Momentum MIS significantly broadens our ability to serve patients and positions ulrich as a true surgical solutions enterprise,” said Eric Lucas, Ph.D., Vice President of Technology for ulrich medical USA.

#spinesurgery #spinesurgeon #ulrichmedical #ulrichmedicalusa #misspine

ulrich medical USA® Announces First Commercial Cases of Flux-CTM 3D-printed Porous Titanium Cervical Interbody Device.

No alternative text description for this image

We thank Neill Wright, M.D., for sharing his comments and pre-/post-op images as we announce the first commercial cases of our 3D-printed titanium cervical interbody device, Flux-C™.

“Flux-C provides all the benefits of a 3D-printed titanium cage, with improved post-operative evaluation of fusion. Flux-C provides multiple options of sizing, such that the interbody can be ideally sized for every patient. The trials and instruments are intuitive and well-designed. It is a great addition to the ulrich cervical portfolio.” Neill M. Wright, M.D., F.A.A.N.S.

#spinesurgery #spinesurgeon #ulrichmedical #ulrichmedicalusa #cervicalspine

ulrich medical USA® New Hire Announcements

November 2022

New Hire Announcements

Alix Furgang

We are pleased to announce Alix Furgang as our new Customer Service Manager. Alix came to ulrich medical USA from Astura Medical where she managed the Customer Service team for two years. She is experienced in leading a committed team that delivers on-time set orders, sales orders, and is adept in process improvement and problem resolution. Alix earned her BS in Biochemistry from Texas Woman’s University, where she was a Research Assistant, conducted enzyme research and interned with Boston Scientific. She lives in the Dallas-Fort Worth Metroplex and is a competitive mountain biker. We welcome Alix to the ulrich team and look forward to the opportunity to work together to take your business to New Heights and BEYOND.

Melissa Pilley

We are pleased to announce Melissa Pilley as the new Regional Sales Manager of the Southwest territory for ulrich medical USA. Melissa has over ten years of medical device sales experience in biologics and spine hardware. For the last three years, she has been the Lead Principal Distributor of her independent spine business. Prior to this, Melissa earned several sales awards in her seven-year tenure at XTANT Medical, and has experience in sales at Arthrex. She also was leader of spine implant education in collaboration with the Chief of Residency at the Banner Orthopedic Residency Program.

Melissa holds a BS in Mass Communications and Public Relations from St. Johns University in New York City, where she played Division I softball. She is based in Phoenix, AZ, and is passionate about helping our distributor partners grow their business.

We welcome Melissa to the ulrich team and look forward to the opportunity to work together to take your business to New Heights and BEYOND.

ulrich Medical USA® Receives 510(k) Clearance for Flux-C™ 3D Printed Porous Titanium Cervical Interbody Prior to NASS

ST. LOUIS, MO (October 13, 2022) — ulrich medical USA, Inc., a privately held medical device company focused on developing and commercializing musculoskeletal implant technologies in the United States, today announced the FDA has given 510(k) clearance of its Flux-C 3D printed porous titanium cervical interbody device.

“Surgeons have many options for cervical interbodies. The Flux-C porous titanium device offers one of the best in class with superior endplate contact and spaces for generous inter-device bone grafting. It is a welcomed complement to their superior array of expandable cages,” said Patrick Maloney, M.D. newest member of ulrich Medical USA’s Surgeon Advisory Board and its recently established Director of Deformity.

Flux-C is manufactured using a 3D printing process called direct metal laser sintering (DMLS). The interbodies are available in multiple parallel and lordotic options in various heights. These porous titanium devices are designed with a large graft window and a side window to allow for improved radiographic imaging.

Eric Lucas, Ph.D., ulrich Medical USA’s Director of Technology states, “We are continuing to develop procedural solutions for reconstruction of all spinal pathologies in collaboration with our Surgeon Advisory Board. We strive to help our surgeons and distributors achieve New Heights and Beyond with integrity, through excellence in design, manufacturing and craftsmanship.”

ulrich medical USA® Announces Corporate Relocation to Dallas-Fort Worth Metroplex

ulrich medical USA® Announces Corporate Relocation to Dallas-Fort Worth Metroplex


ST. LOUIS, MO (September 16, 2022)– ulrich medical USA, Inc., a privately held medical device company focused on developing and commercializing musculoskeletal implant technologies in the United States, today announced it will relocate its US headquarters to Plano, Texas. Its current location is in Chesterfield, Missouri.

“We believe it’s in the best strategic interest of the company to make this move, which supports ulrich medical USA’s strategy for profitable growth as we help our customers and distributors achieve new heights and beyond,” said President and CEO, Hans Stover.

The combination of the recent Sales Agency Agreement with a premier global orthopedic leader and continued organic growth are driving the need for a larger facility. Therefore, the decision was made to expand in a more business-friendly environment like that of Texas. The Dallas-Fort Worth Metroplex was an easy choice, as it has an abundance of well-educated, talented people and attractive communities which should support ulrich medical USA’s growth objectives for years to come. The company will begin transitioning its headquarters to Plano in the first quarter of 2023.


About ulrich Medical USA

ulrich medical USA is privately held, celebrating its 110th year as a family-owned company. Recognized as a leader in vertebral body replacement, ulrich is dedicated to remaining independent and continuing to develop a complete spine solutions portfolio that results in superior patient outcomes for years to come. ulrich medical’s global headquarters is in Ulm, Germany.


© ulrich medical USA. All rights reserved.



ulrich medical USA®, NASS 2022 Exhibitor

Nass Suite Signup

Join us at the NASS 37th Annual Meeting in Chicago, IL on October 12-14th Join Us at our suite to meet with our sales team and learn more about the latest advances in orthopedic health care technology.

To sign up with your Ulrich regional sales contact:

ulrich medical USA® Announces Exceptional First Quarter Sales

Resilient Rebound From COVID Impacts

ST. LOUIS, MO (May 21, 2021) – ulrich medical USA, Inc., a medical device company focused on developing and commercializing musculoskeletal implant technologies in the United States, reported that the first quarter of 2021 marked the strongest quarterly revenue in the company’s history.

Despite the challenges presented by COVID, monthly sales have set a new bar for ulrich medical USA. In addition, robust progress continues on the development of multiple new products that are poised to uphold the company’s century-long tradition of innovation and efficacy.

“We are grateful to our customers for allowing us to continue serving their needs,” said Pete Richardson, Vice President, Finance and Administration, ulrich medical USA. “We are also extremely proud of our team – our sales agents and managers in the field, and our in-house personnel. They have all pitched in and worked creatively to keep the gears turning, in the face of all the obstacles presented by COVID, and results like these show that our combined efforts truly matter to our customers.”

ulrich medical USA® Brings Strong Momentum® to U.S. Product Launch

Announces Nationwide Rollout of Innovative Rod-Screw System

ST. LOUIS, MO (July 13, 2020) – ulrich medical USA, Inc., a medical device company focused on developing and commercializing musculoskeletal implant technologies in the United States announced the nationwide commercial release of the Momentum Posterior Spinal Fixation System.

“After completing hundreds of procedures during the alpha launch, Momentum has already made its mark with an enthusiastic reception and positive reviews from our alpha surgeon users,” said Erika Strecker-Laskey, Chief Commercial Officer, ulrich medical USA. “Even amid the healthcare challenges presented by the Covid-19 crisis, we have seen steadily-increasing use of Momentum during this time and a growing demand for more sets.”

Dr. Christopher F. Wagener of Allentown, PA performed multiple procedures with Momentum during the alpha launch period and said, “Momentum gives surgeons exactly what they need, both simplicity and reliability.”

Developed in St. Louis, Missouri, the new Momentum rod-screw system includes polyaxial, reduction, and iliac screws, and is compatible with ulrich medical USA’s neon3® Universal OCT Spinal Stabilization System via transition rods and connectors. This offering allows for surgical constructs capable of bridging from the sacroiliac to the cervical spine. All screws for the Momentum System are offered in a range of lengths, diameters, and angulations to accommodate unique patient anatomy. Screws are available from Ø 4.5mm to Ø 10.0mm, and in lengths from 25mm to 110mm. The system also offers both titanium and cobalt chrome rods (curved and straight) in Ø 5.5mm and Ø 6.0mm diameters. Single-use drills and taps guarantee consistent instrument performance for optimized clinical results. In addition, specialty surgical instrument modules are available for iliac fixation and deformity (basic) applications.